WHO ICTRP trial

A clinical study on Rheumatoid Arthritis(Waja -ul- Mufasil) and its management…

CTRI/2022/12/047920 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2022/12/047920
Public title A clinical study on Rheumatoid Arthritis(Waja -ul- Mufasil) and its management in unani medicine
Scientific title Clinical study on waja-ul-mufasil (Rheumatoid Arthritis)and its management in unani medicine
Primary sponsor PG Dept Of MOALEJAT General Medicine
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Interventions Intervention1: Clinical study on waja-ul-mufasil(Rheumatoid Arthritis)and its management in unani medicines.: Each patient will be treated for 51 days with 21 days decoction (cuscuta reflexa,polypodium vulgare,hemidesmus indicus,apium…
Registration date Jun 12, 2022
Target size 40
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations